| MolName | 7-[2-[4-[(E)-2-[4-[2-(2-carboxy-4,8-dioxoquinolin-7-yl)hydrazinyl]-2-sulfophenyl]ethenyl]-3-sulfophenyl]hydrazinyl]-4,8-dioxoquinoline-2-carboxylic acid |
| MolecularFormula | C34H22N6O14S2 |
| Smiles | OC(C(N=C(C1=CC=C2NNc3cc(S(O)(=O)=O)c(/C=C/c(ccc(NNC(C4=O)=CC=C5C4=NC(C(O)=O)=CC5=O)c4)c4S(O)(=O)=O)cc3)C2=O)=CC1=O)=O |
| InChI | InChI=1S/C34H22N6O14S2/c41-25-13-23(33(45)46)35-29-19(25)7-9-21(31(29)43)39-37-17-5-3-15(27(11-17)55(49,50)51)1-2-16-4-6-18(12-28(16)56(52,53)54)38-40-22-10-8-20-26(42)14-24(34(47)48)36-30(20)32(22)44/h1-14,37-40H,(H,45,46)(H,47,48)(H,49,50,51)(H,52,53,54 |
| InChIK | LYIWHPNLWYJZFW-UHFFFAOYSA-N |
| TotalMolweight | 802.709 |
| Molweight | 802.709 |
| MonoisotopicMass | 802.063544 |
| CLogP | -2.4704 |
| CLogS | -2.154 |
| H Acceptors | 20 |
| H Donors | 8 |
| TotalSurfaceArea | 534.62 |
| Relative PSA | 0.48008 |
| PolarSurfaceArea | 341.22 |
| Druglikeness | 2.2323 |
| Mutagenic | high |
| Tumorigenic | high |
| Reproductive Effective | none |
| Irritant | high |
| Nasty Functions | twice activated DB |
| Shape Index | 0.5 |
| Fragments | 1 |
| Non HAtoms | 56 |
| NonCHAtoms | 22 |
| Electronegative Atoms | 22 |
| Rotatable Bond | 12 |
| Rings Closures | 6 |
| Small Rings | 6 |
| Aromatic Rings | 2 |
| Aromatic Atoms | 12 |
| Sp3Atoms | 6 |
| Symmetricatoms | 29 |
| AcidicOxygens | 4 |
| StereoCon |
Click to Load Molecule:
1 - 7-[2-[4-[(E)-2-[4-[2-(2-carboxy-4,8-dioxoquinolin-7-yl)hydrazinyl]-2-sulfophenyl]ethenyl]-3-sulfophenyl]hydrazinyl]-4,8-dioxoquinoline-2-carboxylic acid | 2 - 7-[2-[4-[(E)-2-[4-[2-(2-carboxy-4,8-dioxoquinolin-7-yl)hydrazinyl]-2-sulfophenyl]ethenyl]-3-sulfophenyl]hydrazinyl]-4,8-dioxoquinoline-2-carboxylic acid